Literature DB >> 33505957

The Adipose Microenvironment Dysregulates the Mammary Myoepithelial Cells and Could Participate to the Progression of Breast Cancer.

Laetitia Delort1, Juliette Cholet1, Caroline Decombat1, Marion Vermerie1, Charles Dumontet2, Florence A Castelli3, François Fenaille3, Céline Auxenfans4, Adrien Rossary1, Florence Caldefie-Chezet1.   

Abstract

Breast cancer is the most common cancer among women worldwide. Overweight and obesity are now recognized as established risk factors for this pathology in postmenopausal women. These conditions are also believed to be responsible for higher recurrence and mortality rates. Reciprocal interactions have been described between adipose and cancer cells. An adipose microenvironment favors a greater proliferation of cancer cells, their invasion and even resistance to anti-cancer treatments. In addition, the chronic low-grade inflammation observed in obese individuals is believed to amplify these processes. Among the cell types present in the breast, myoepithelial cells (MECs), located at the interface of the epithelial cells and the stroma, are considered "tumor suppressor" cells. During the transition from ductal carcinoma in situ to invasive cancer, disorganization or even the disappearance of MECs is observed, thereby enhancing the ability of the cancer cells to migrate. As the adipose microenvironment is now considered as a central actor in the progression of breast cancer, our objective was to evaluate if it could be involved in MEC functional modifications, leading to the transition of in situ to invasive carcinoma, particularly in obese patients. Through a co-culture model, we investigated the impact of human adipose stem cells from women of normal weight and obese women, differentiated or not into mature adipocytes, on the functionality of the MECs by measuring changes in viability, apoptosis, gene, and miRNA expressions. We found that adipose cells (precursors and differentiated adipocytes) could decrease the viability of the MECs, regardless of the original BMI. The adipose cells could also disrupt the expression of the genes involved in the maintenance of the extracellular matrix and to amplify the expression of leptin and inflammatory markers. miR-122-5p and miR-132-3p could also be considered as targets for adipose cells. The metabolite analyses revealed specific profiles that may be involved in the growth of neoplastic cells. All of these perturbations could thus be responsible for the loss of tumor suppressor status of MECs and promote the transition from in situ to invasive carcinoma.
Copyright © 2021 Delort, Cholet, Decombat, Vermerie, Dumontet, Castelli, Fenaille, Auxenfans, Rossary and Caldefie-Chezet.

Entities:  

Keywords:  miRNA; breast cancer progression; human adipose stem cells; mature adipocytes; metabolomics; myoepithelial cells; obesity

Year:  2021        PMID: 33505957      PMCID: PMC7829501          DOI: 10.3389/fcell.2020.571948

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  54 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  αvβ6 Expression in myoepithelial cells: a novel marker for predicting DCIS progression with therapeutic potential.

Authors:  Michael D Allen; John F Marshall; J Louise Jones
Journal:  Cancer Res       Date:  2014-10-15       Impact factor: 12.701

3.  Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.

Authors:  Pang-Kuo Lo; Yongshu Zhang; Yuan Yao; Benjamin Wolfson; Justine Yu; Shu-Yan Han; Nadire Duru; Qun Zhou
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

4.  Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma.

Authors:  Thierry Jardé; Florence Caldefie-Chézet; Mireille Damez; Florence Mishellany; Frédérique Penault-Llorca; Jean Guillot; Marie Paule Vasson
Journal:  Oncol Rep       Date:  2008-04       Impact factor: 3.906

5.  Optimization of a culture medium for the differentiation of preadipocytes into adipocytes in a monolayer.

Authors:  C Lequeux; C Auxenfans; A Mojallal; M Sergent; O Damour
Journal:  Biomed Mater Eng       Date:  2009       Impact factor: 1.300

6.  Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen.

Authors:  Samar Basu; Kristell Combe; Fabrice Kwiatkowski; Florence Caldefie-Chézet; Frédérique Penault-Llorca; Yves-Jean Bignon; Marie-Paule Vasson
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

7.  Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics.

Authors:  Franck Giacomoni; Gildas Le Corguillé; Misharl Monsoor; Marion Landi; Pierre Pericard; Mélanie Pétéra; Christophe Duperier; Marie Tremblay-Franco; Jean-François Martin; Daniel Jacob; Sophie Goulitquer; Etienne A Thévenot; Christophe Caron
Journal:  Bioinformatics       Date:  2014-12-19       Impact factor: 6.937

8.  The complex role of branched chain amino acids in diabetes and cancer.

Authors:  Thomas M O'Connell
Journal:  Metabolites       Date:  2013-10-14

9.  Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.

Authors:  Tamara Chamberlin; Joseph V D'Amato; Lisa M Arendt
Journal:  Breast Cancer Res       Date:  2017-11-29       Impact factor: 6.466

Review 10.  Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.

Authors:  Manuel Picon-Ruiz; Cynthia Morata-Tarifa; Janeiro J Valle-Goffin; Eitan R Friedman; Joyce M Slingerland
Journal:  CA Cancer J Clin       Date:  2017-08-01       Impact factor: 508.702

View more
  4 in total

1.  Chronic Leptin Treatment Induces Epithelial-Mesenchymal Transition in MCF10A Mammary Epithelial Cells.

Authors:  Juan Carlos Juárez-Cruz; Michal Okoniewski; Mónica Ramírez; Carlos Ortuño-Pineda; Napoleón Navarro-Tito; Eduardo Castañeda-Saucedo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-02-23       Impact factor: 2.673

2.  Promising Colloidal Rhenium Disulfide Nanosheets: Preparation and Applications for In Vivo Breast Cancer Therapy.

Authors:  Yiwan Song; Yufeng Yuan; Xiao Peng; Zheng Peng; Hao Liu; Yingxin Zhou; Xiaoying Zhang; Feifan Zhou; Jun Song; Junle Qu
Journal:  Nanomaterials (Basel)       Date:  2022-06-06       Impact factor: 5.719

Review 3.  Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments.

Authors:  Tsung-Chieh Lin; Michael Hsiao
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

4.  The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.

Authors:  Daniela Nachmanson; Adam Officer; Hidetoshi Mori; Jonathan Gordon; Mark F Evans; Joseph Steward; Huazhen Yao; Thomas O'Keefe; Farnaz Hasteh; Gary S Stein; Kristen Jepsen; Donald L Weaver; Gillian L Hirst; Brian L Sprague; Laura J Esserman; Alexander D Borowsky; Janet L Stein; Olivier Harismendy
Journal:  NPJ Breast Cancer       Date:  2022-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.